As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The new online Learning Center with new content can still be found under the “Training” folder on ...